These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nuclear reprogramming with a non-integrating human RNA virus. Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591 [TBL] [Abstract][Full Text] [Related]
4. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34 Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949 [TBL] [Abstract][Full Text] [Related]
5. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4. Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994 [TBL] [Abstract][Full Text] [Related]
6. Activation of pluripotency genes by a nanotube-mediated protein delivery system. Cho SJ; Choi HW; Cho J; Jung S; Seo HG; Do JT Mol Reprod Dev; 2013 Dec; 80(12):1000-8. PubMed ID: 24038603 [TBL] [Abstract][Full Text] [Related]
7. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Li Y; Zhang Q; Yin X; Yang W; Du Y; Hou P; Ge J; Liu C; Zhang W; Zhang X; Wu Y; Li H; Liu K; Wu C; Song Z; Zhao Y; Shi Y; Deng H Cell Res; 2011 Jan; 21(1):196-204. PubMed ID: 20956998 [TBL] [Abstract][Full Text] [Related]
8. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells. Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760 [TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells from goat fibroblasts. Song H; Li H; Huang M; Xu D; Gu C; Wang Z; Dong F; Wang F Mol Reprod Dev; 2013 Dec; 80(12):1009-17. PubMed ID: 24123501 [TBL] [Abstract][Full Text] [Related]
10. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells. Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167 [TBL] [Abstract][Full Text] [Related]
11. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells. Febbraro F; Chen M; Denham M Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617 [TBL] [Abstract][Full Text] [Related]
12. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction. Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107 [TBL] [Abstract][Full Text] [Related]
13. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells. Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079 [TBL] [Abstract][Full Text] [Related]
14. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs). Greder LV; Post J; Dutton JR Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297 [TBL] [Abstract][Full Text] [Related]
15. Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential. Ohnuki M; Tanabe K; Sutou K; Teramoto I; Sawamura Y; Narita M; Nakamura M; Tokunaga Y; Nakamura M; Watanabe A; Yamanaka S; Takahashi K Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12426-31. PubMed ID: 25097266 [TBL] [Abstract][Full Text] [Related]
16. Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells. Vazquez-Martin A; Vellon L; Quirós PM; Cufí S; Ruiz de Galarreta E; Oliveras-Ferraros C; Martin AG; Martin-Castillo B; López-Otín C; Menendez JA Cell Cycle; 2012 Mar; 11(5):974-89. PubMed ID: 22333578 [TBL] [Abstract][Full Text] [Related]
17. Identification of Oct4-activating compounds that enhance reprogramming efficiency. Li W; Tian E; Chen ZX; Sun G; Ye P; Yang S; Lu D; Xie J; Ho TV; Tsark WM; Wang C; Horne DA; Riggs AD; Yip ML; Shi Y Proc Natl Acad Sci U S A; 2012 Dec; 109(51):20853-8. PubMed ID: 23213213 [TBL] [Abstract][Full Text] [Related]
18. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming. Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733 [TBL] [Abstract][Full Text] [Related]
19. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors. Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141 [TBL] [Abstract][Full Text] [Related]
20. Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells. Phang RZ; Tay FC; Goh SL; Lau CH; Zhu H; Tan WK; Liang Q; Chen C; Du S; Li Z; Tay JC; Wu C; Zeng J; Fan W; Toh HC; Wang S Stem Cells Transl Med; 2013 Dec; 2(12):935-45. PubMed ID: 24167318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]